Bausch + Lomb, a subsidiary of Bausch Health, announced the resignation of board members Brett M. Icahn and Gary Hu.
2 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bausch + Lomb, a subsidiary of Bausch Health, announced the resignation of board members Brett M. Icahn and Gary Hu.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Board members Brett M. Icahn and Gary Hu resigned from Bausch + Lomb's board.1 source
Brent Saunders acknowledged operational challenges at Bausch + Lomb.1 source
Keep exploring
The entities involved
-
Bausch Health
multinational specialty drugs company based in Laval, Quebec, Canada
Nothing else this week.
-
Bausch & Lomb
American company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireBausch + Lomb Announces Board Changes VAUGHAN, Ontario, August 18, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people s
- StockStoryBLCO Q2 Deep Dive: Product Launches Offset Margin Pressures, Management Highlights Pipeline Investments Eyecare company Bausch + Lomb (NYSE:BLCO) announced better-than-expected revenue in Q2 CY2025,